FDA agrees to review Moderna’s amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval
Last week, the US Food and Drug Administration (FDA) had said it will not review Moderna’s application for its experiment...
Impressions : 1880
FDA grants accelerated approval to Wegovy for treating MASH; Lilly, Superluminal ink US$1.3 bn AI deal to treat obesity
This week’s Phispers brings you updates on key drug approvals. The US Food and Drug Administration (FDA) has granted acce...
Impressions : 2015
FDA grants accelerated nod to Boehringer’s lung cancer med; reinstates ousted CBER chief Vinay Prasad
The US Food and Drug Administration (FDA) has granted an accelerated approval to Boehringer Ingelheim’s Hernexeos (zonger...
Impressions : 1869
Astra targets US$ 80 bn revenue by 2030, invests US$ 1.5 bn in ADC plant; Lilly’s weekly insulin scores late-stage wins
In this week’s news, AstraZeneca has laid out an ambitious plan to achieve US$ 80 billion in revenue by 2030. The drugmak...
Impressions : 1036
Two Regeneron drugs bag approval; FDA chief links drug shortages to low-priced generics
Like last week, this week too saw several drug approvals. The US Food and Drug Administration (FDA) approved Regeneron’s ...
Impressions : 1721
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.